Required Medical Tests for GLP-1 Use: What Your Doctor Should Monitor

Before You Start: The Baseline Tests

Before your first GLP-1 injection, your healthcare provider should establish a baseline picture of your metabolic and organ health. This isn't optional busywork. These tests serve as your reference point for detecting any changes once the medication is in your system.

Thyroid function tests (TSH and free T4) are foundational. While GLP-1 medications don't directly cause thyroid disease, they can accelerate weight loss in ways that sometimes unmask underlying thyroid conditions, particularly medullary thyroid carcinoma risk in people with personal or family history. That's why your thyroid status before starting matters. Similarly, kidney function—measured through creatinine and estimated glomerular filtration rate (eGFR)—establishes where you're starting. GLP-1s are metabolized through your kidneys, so knowing your baseline function helps your doctor determine if dose adjustments are needed and what your kidney can safely handle. Liver function tests (AST, ALT, bilirubin) round out the organ picture. Lastly, lipase and amylase are checked to rule out pancreatitis before starting, since acute pancreatitis is a known rare adverse event associated with GLP-1 use.

Your provider may also order a fasting glucose and comprehensive metabolic panel to understand your current metabolic state. This becomes your before-and-after snapshot once the medication takes effect.

While You're On It: What Active Monitoring Looks Like

Once you begin treatment, your monitoring schedule typically follows a pattern: labs around week 4 after starting or dosage changes, then every 3 to 6 months during maintenance. The exact frequency depends on your baseline health, any comorbidities, and your provider's preference, but this cadence is standard across major trials like STEP 1 and SURMOUNT-1.

What your doctor is actually looking for during active treatment is how your kidneys and metabolic markers are responding. Creatinine and eGFR will be rechecked because rapid weight loss can initially affect kidney function readings—this usually normalizes, but catching it early matters. Hemoglobin A1c (if diabetic) will drop as your blood sugar control improves; this is expected and good, but it also guides whether your other diabetes medications need adjustment to avoid hypoglycemia. Lipid panels reveal changes in cholesterol and triglycerides, which often improve on GLP-1s but need monitoring to ensure you're getting the cardiovascular benefit you expect.

Thyroid markers should be rechecked if you had any borderline findings at baseline or if you develop symptoms like unexplained fatigue or weight loss plateau. Liver function tests repeat because some people experience minor transient elevations in liver enzymes during rapid weight loss from any source. None of these elevations are typically serious, but your doctor needs to distinguish between expected metabolic changes and something that warrants action.

Pancreatic enzymes (lipase and amylase) don't need routine repeat testing if you're asymptomatic, but they're measured immediately if you develop abdominal pain. That's the critical distinction: routine monitoring checks the big picture; symptom-triggered testing rules out specific complications.

Red Flags That Need Urgent Attention

Some symptoms warrant contacting your doctor immediately, not waiting for your next scheduled lab. Persistent severe abdominal pain, especially in the upper abdomen, can signal acute pancreatitis and should be evaluated with lipase, amylase, and imaging. Sustained yellowing of skin or eyes suggests liver dysfunction. Unexplained swelling in the neck or difficulty swallowing could indicate thyroid changes. Shortness of breath, chest pain, or severe dizziness need emergency evaluation regardless of your GLP-1 use—these could indicate cardiac issues unrelated to the medication but requiring urgent assessment.

Vomiting that won't stop, severe dehydration, or signs of acute kidney injury (significantly reduced urination, sudden weight gain from fluid retention, fatigue) also warrant immediate medical attention. GLP-1s slow gastric emptying, which is therapeutic for weight loss, but severe nausea or vomiting can become a medical problem if it prevents you from staying hydrated or taking necessary medications.

Why Monitoring Frequency Matters

The monitoring schedule isn't arbitrary. Early months on GLP-1 involve the most dramatic metabolic shifts—rapid weight loss, blood sugar changes, and the body adjusting to a new hormone signal. That's when problems are most likely to surface or when you're most likely to need a dose adjustment. Once you've been stable on a maintenance dose for several months, less frequent monitoring is reasonable, though most providers continue annual comprehensive labs for long-term users.

Your healthcare provider is your partner in this, not just ordering tests because protocols exist. If you've been on GLP-1 therapy for a year with stable health markers and no symptoms, asking about stretching labs to every 6 or 12 months is a reasonable conversation. Conversely, if you develop new health issues, gain weight despite treatment, or have unexplained symptoms, labs become urgent again. This is dynamic, personalized medicine, not a set-it-and-forget-it checkbox system. Staying engaged with your own numbers—asking what they mean, why they've changed, what they tell you about how your body is responding—transforms routine monitoring from bureaucracy into actionable health information.